WallStreetZenWallStreetZen

NASDAQ: SGMT
Sagimet Biosciences Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Sagimet Biosciences earnings were -$45.6M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest SGMT earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$16.2M, up 10.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SGMT reported annual earnings of -$45.6M, with 63.5% growth.

SGMT earnings history

Current Revenue
$0.0
Current Earnings
-$45.6M
Current Profit Margin
0%

SGMT Return on Equity

Current Company
-26%
Current Industry
-2%
Current Market
34.1%
SGMT's Return on Equity (-26%)... subscribe to Premium to read more.
High Return on Equity Performance

SGMT undefined

Current Company
-25.4%
Current Industry
-0.4%
SGMT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SGMT announces earnings.

SGMT undefined

Current Company
-29.25%
Current Industry
5.9%
SGMT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SGMT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SGMT-$45.42M-$45.57MN/A-$1.45
BHST-$5.74M-$12.91MN/A-$0.80
TNXP-$126.62M-$130.04MN/A-$176.60
ALEC-$110.08M-$119.05MN/A-$1.23
CCCC-$96.95M-$105.32MN/A-$1.52
View Top Biotech Stocks

Sagimet Biosciences Earnings Reports & History FAQ

What were Sagimet Biosciences's earnings last quarter?

Sagimet Biosciences (NASDAQ: SGMT) reported Q4 2024 earnings per share (EPS) of -$0.50, up 189.29% year over year. Total SGMT earnings for the quarter were -$16.20 million. In the same quarter last year, Sagimet Biosciences's earnings per share (EPS) was $0.56.

If you're new to stock investing, here's how to buy Sagimet Biosciences stock.

Is Sagimet Biosciences profitable or losing money?

As of the last Sagimet Biosciences earnings report, Sagimet Biosciences is currently losing money. Sagimet Biosciences's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$45.57 million, a 63.46% increase year over year.

What was SGMT's earnings growth in the past year?

As of Sagimet Biosciences's earnings date in Q2 2025, Sagimet Biosciences's earnings has grown year over year. SGMT earnings in the past year totalled -$45.57 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.